Abstract:The title compound 2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4- diethoxy-, 2,3,3a, 4-tetrahydrochromeno[3,4-d][1,2,3]diazaphosphole 2 (C29H30Cl2N3O7P, Mr = 633.44) was synthesized and its structure was characterized by IR, MS, H-1 NMR, C-13 NMR, (31)p NMR, elemental analysis and single-crystal X-ray diffraction. It crystallizes in triclinic, space group P (1) over bar, a = 9.1549(3), b = 10.7168(4), c = 17.6272(6) angstrom, alpha = 102.9363(12), beta = 90.2713(9), gamma = 117.4265(10)degrees, V = 1484.41(9) angstrom, Z = 2,mu(MoK alpha) = 0.323, F(000) = 658, Z = 2, D-c = 1.417 g/cm(3), the final R = 0.0687 and wR = 0.2066 for 4943 observed reflections (I > 2 sigma(I)). X-ray analysis reveals that the diazaphospholine ring is almost planar and the two ethoxy groups bonded on the 3a- and 4-positions are in trans configurations. Its antiproliferative activity was also tested in vitro against four human tumor cell lines.

4-Des-oxy-4β-(4-methoxy-carbonyl-1,2,3-triazol-1-yl)podophyllotoxin dichloro-methane solvate

4-Des-oxy-4β-[(5-meth-oxy-1H-indol-3-yl)oxalylamino]podophyllotoxin methanol solvate.

10-Hexyl-10h-phenothiazine-3-carbaldehyde

4-Β-azido-4-desoxypodophyllotoxin

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

3-[3-Methyl-4-(4-nitro-benzyl-idene-amino)-5-sulfanyl-idene-4,5-dihydro-1H-1,2,4-triazol-1-yl]-1,3-diphenyl-propan-1-one dichloro-methane monosolvate.

3-[(2-Hydroxybenzylidene) Hydrazinocarbonyl]-1h-1,2,4-Triazole Ethanol Solvate

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

Synthesis,Crystal Structure and Anti-tumor Activity of 2-（2-Chloro-4-nitrophenyl）-4-（4-chlorophenyl）-3a,4-diethoxy-2,3,3a,4-tetrahydrochromeno[3,4-d][1,2,3]diazaphosphole

4&#946;-Hydroxy-12,13-epoxytrichothec-9-ene

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

(5Ar,8ar,9r)-9-(3,4,5-trimethoxyphenyl)5a,6,8a,9-tetrahydrofuro[3 ',4 ': 6,7]Naphtho[2,3-D][1,3]dioxole-5,8-dione

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline

4 Beta-Hydroxy-12,13-Epoxytrichothec-9-Ene

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

3,5-Bis(salicylideneamino)-1h-1,2,4-triazole Methanol Solvate

4-Amino-5-(4-chlorophenoxymethyl)-2-(2-cyanoethyl)-2h-1,2,4-triazole-3(4h)-thione Monohydrate

4-Difluoromethyl-3-methyl-1-phenyl-1h-1,2,4-triazol-5(4h)-one

4-(1H-1,2,4-Triazol-3-yl)-4H-1,2,4-triazole monohydrate

9,10,11,12-Tetrachloro-12b-hydroxy-2,12c-dimethyl-3a,5,6, 12c-tetrahydrothiazalo[4,5-c][1,4]oxazepino[5,4-a]isoindol-8-one monohydrate